Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
Central serous chorioretinopathy (CSC) is a common cause of visual impairment in patients generally aged 20 to 60 and it is characterized by acute or chronic neurosensory detachments of the retina. Although CSC resolves spontaneously in most cases, in some patients it may cause permanent visual impa...
Saved in:
Main Authors: | Massimo Nicolò (Author), Lorenzo Ferro Desideri (Author), Aldo Vagge (Author), Carlo Enrico Traverso (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Serous Chorioretinopathy: Treatment with Laser
by: Maurizio Battaglia Parodi, et al.
Published: (2020) -
Central Serous Chorioretinopathy Classification
by: Manuel Vilela, et al.
Published: (2020) -
Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review
by: Francesco Sartini, et al.
Published: (2020) -
The Role of Atropine in Preventing Myopia Progression: An Update
by: Alberto Chierigo, et al.
Published: (2022) -
The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy
by: Stefano Da Pozzo, et al.
Published: (2021)